Cathy Traz

Cathy heads global advocacy at Bristol Myers Squibb (BMS), developing and advocating company positions on priority issues to maximize patient access and promote a strong climate of biopharmaceutical innovation, as well as working with advocacy organizations and other key stakeholders about the value of innovative medicines. Cathy also leads the BMS Global Advocacy Digital Health initiative, focused on engaging with advocacy organizations to explore FDA patient-focused drug development guidance (21st Century Cures) and other guidance (EMA, HTA) on patient experience data through social media data and companion DH technology partnerships; driving internal and external assessments of early patient engagement to develop strategy; creating an end to end, comprehensive, expert patient engagement process for inclusiveness across the entire BMS continuum.